Tumor-suppressive activity of lunatic fringe in prostate through differential modulation of notch receptor activation

Neoplasia (United States)

Volumn 16, Issue 2, 2014, Pages 158-167

  Zhang, Shubing ^a   Chung, Wen Cheng ^a   Wu, Guanming ^b   Egan, Sean E ^c   Xu, Keli ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; LUNATIC FRINGE PROTEIN; N ACETYLGLUCOSAMINYLTRANSFERASE; NOTCH RECEPTOR; NOTCH1 RECEPTOR; NOTCH2 RECEPTOR; NOTCH4 RECEPTOR; O FUCOSYLPEPTIDE 3 BETA N ACETYLGLUCOSAMINYLTRANSFERASE; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HES 1; TRANSCRIPTION FACTOR HES 5; TRANSCRIPTION FACTOR HEY 2; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG; GLYCOSYLTRANSFERASE; HOMEODOMAIN PROTEIN; LFNG PROTEIN, HUMAN; NKX3-1 PROTEIN, HUMAN; NOTCH1 PROTEIN, HUMAN; NOTCH2 PROTEIN, HUMAN; NOTCH3 PROTEIN, HUMAN; NOTCH4 PROTEIN, HUMAN; ONCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; FLOW CYTOMETRY; GENE DELETION; GENE EXPRESSION; GENE SILENCING; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NKX3.1 GENE; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATIC INTRAEPITHELIAL NEOPLASIA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; WESTERN BLOTTING; ANIMAL; GENE EXPRESSION REGULATION; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROSTATE; PROSTATE TUMOR;

ANIMALS; CELL PROLIFERATION; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; GLYCOSYLTRANSFERASES; HOMEODOMAIN PROTEINS; HUMANS; MALE; MICE, KNOCKOUT; PROSTATE; PROSTATIC NEOPLASMS; PROTO-ONCOGENE PROTEINS; RECEPTOR, NOTCH1; RECEPTOR, NOTCH2; RECEPTORS, ANDROGEN; RECEPTORS, NOTCH; TRANSCRIPTION FACTORS;

EID: 84900446105     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.131870     Document Type: Article

References (39)

1. Wang XD, Leow CC, Zha J, Tang Z, Modrusan Z, Radtke F, Aguet M, de Sauvage FJ, and Gao WQ (2006). Notch signaling is required for normal prostatic epithelial cell proliferation and differentiation. Dev Biol 290, 66-80.
2. Wu X, Xu K, Zhang L, Deng Y, Lee P, Shapiro E, Monaco M, Makarenkova HP, Li J, Lepor H, et al. (2011). Differentiation of the ductal epithelium and smooth muscle in the prostate gland are regulated by the Notch/PTEN-dependent mechanism. Dev Biol 356, 337-349.
3. Wang XD, Shou J, Wong P, French DM, and Gao WQ (2004). Notch1- expressing cells are indispensable for prostatic branching morphogenesis during development and re-growth following castration and androgen replacement. J Biol Chem 279, 24733-24744.
4. Shou J, Ross S, Koeppen H, de Sauvage FJ, and Gao WQ (2001). Dynamics of notch expression during murine prostate development and tumorigenesis. Cancer Res 61, 7291-7297.
5. Valdez JM, Zhang L, Su Q, Dakhova O, Zhang Y, Shahi P, Spencer DM, Creighton CJ, Ittmann MM, and Xin L (2012). Notch and TGFβ form a reciprocal positive regulatory loop that suppresses murine prostate basal stem/ progenitor cell activity. Cell Stem Cell 11, 676-688.
6. Haines N and Irvine KD (2003). Glycosylation regulates Notch signalling. Nat Rev Mol Cell Biol 4, 786-797.
7. Cohen B, Bashirullah A, Dagnino L, Campbell C, Fisher WW, Leow CC, Whiting E, Ryan D, Zinyk D, Boulianne G, et al. (1997). Fringe boundaries coincide with Notch-dependent patterning centres in mammals and alter Notch-dependent development in Drosophila. Nat Genet 16, 283-288.
8. Johnston SH, Rauskolb C, Wilson R, Prabhakaran B, Irvine KD, and Vogt TF (1997). A family of mammalian Fringe genes implicated in boundary determination and the Notch pathway. Development 124, 2245-2254.
9. Ousset M, Van Keymeulen A, Bouvencourt G, Sharma N, Achouri Y, Simons BD, and Blanpain C (2012). Multipotent and unipotent progenitors contribute to prostate postnatal development. Nat Cell Biol 14, 1131-1138.
10. Wang ZA, Mitrofanova A, Bergren SK, Abate-Shen C, Cardiff RD, Califano A, and Shen MM (2013). Lineage analysis of basal epithelial cells reveals their unexpected plasticity and supports a cell-of-origin model for prostate cancer heterogeneity. Nat Cell Biol 15, 274-283.
11. Goldstein AS, Huang J, Guo C, Garraway IP, and Witte ON (2010). Identification of a cell of origin for human prostate cancer. Science 329, 568-571.
12. Lawson DA, Zong Y, Memarzadeh S, Xin L, Huang J, and Witte ON (2010). Basal epithelial stem cells are efficient targets for prostate cancer initiation. Proc Natl Acad Sci USA 107, 2610-2615.
13. Taylor RA, Toivanen R, Frydenberg M, Pedersen J, Harewood L, Australian Prostate Cancer B, Collins AT, Maitland NJ, and Risbridger GP (2012). Human epithelial basal cells are cells of origin of prostate cancer, independent of CD133 status. Stem Cells 30, 1087-1096.
14. Choi N, Zhang B, Zhang L, Ittmann M, and Xin L (2012). Adult murine prostate basal and luminal cells are self-sustained lineages that can both serve as targets for prostate cancer initiation. Cancer Cell 21, 253-265.
15. Xu K, Usary J, Kousis PC, Prat A, Wang DY, Adams JR, Wang W, Loch AJ, Deng T, Zhao W, et al. (2012). Lunatic fringe deficiency cooperates with the Met/ Caveolin gene amplicon to induce basal-like breast cancer. Cancer Cell 21, 626-641.
16. Xu K, Nieuwenhuis E, Cohen BL, Wang W, Canty AJ, Danska JS, Coultas L, Rossant J, Wu MY, Piscione TD, et al. (2010). Lunatic Fringe-mediated Notch signaling is required for lung alveogenesis. Am J Physiol Lung Cell Mol Physiol 298, L45-L56.
17. Tsao PN, Wei SC, Wu MF, Huang MT, Lin HY, Lee MC, Lin KM, Wang IJ, Kaartinen V, Yang LT, et al. (2011). Notch signaling prevents mucous metaplasia in mouse conducting airways during postnatal development. Development 138, 3533-3543.
18. Lilla JN, Joshi RV, Craik CS, and Werb Z (2009). Active plasma kallikrein localizes to mast cells and regulates epithelial cell apoptosis, adipocyte differentiation, and stromal remodeling during mammary gland involution. J Biol Chem 284, 13792-13803.
19. Xiao Y, Ye Y, Zou X, Jones S, Yearsley K, Shetuni B, Tellez J, and Barsky SH (2011). The lymphovascular embolus of inflammatory breast cancer exhibits a Notch 3 addiction. Oncogene 30, 287-300.
20. Alcalay M, Meani N, Gelmetti V, Fantozzi A, Fagioli M, Orleth A, Riganelli D, Sebastiani C, Cappelli E, Casciari C, et al. (2003). Acute myeloid leukemia fusion proteins deregulate genes involved in stem cell maintenance and DNA repair. J Clin Invest 112, 1751-1761.
21. Goldstein AS and Witte ON (2012). A plethora of progenitors in the post-natal prostate. EMBO Rep 13, 1036-1037.
22. Burger PE, Gupta R, Xiong X, Ontiveros CS, Salm SN, Moscatelli D, and Wilson EL (2009). High aldehyde dehydrogenase activity: a novel functional marker of murine prostate stem/progenitor cells. Stem Cells 27, 2220-2228.
23. van Leenders G, van Balken B, Aalders T, Hulsbergen-van de Kaa C, Ruiter D, and Schalken J (2002). Intermediate cells in normal and malignant prostate epithelium express c-MET: implications for prostate cancer invasion. Prostate 51, 98-107.
24. van Leenders GJ, Sookhlall R, Teubel WJ, de Ridder CM, Reneman S, Sacchetti A, Vissers KJ, van Weerden W, and Jenster G (2011). Activation of c-MET induces a stem-like phenotype in human prostate cancer. PLoS One 6, e26753.
25. Park JH, Walls JE, Galvez JJ, Kim M, Abate-Shen C, Shen MM, and Cardiff RD (2002). Prostatic intraepithelial neoplasia in genetically engineered mice. Am J Pathol 161, 727-735.
26. Abdulkadir SA, Magee JA, Peters TJ, Kaleem Z, Naughton CK, Humphrey PA, and Milbrandt J (2002). Conditional loss of Nkx3.1 in adult mice induces prostatic intraepithelial neoplasia. Mol Cell Biol 22, 1495-1503.
27. Kim MJ, Bhatia-Gaur R, Banach-Petrosky WA, Desai N, Wang Y, Hayward SW, Cunha GR, Cardiff RD, Shen MM, and Abate-Shen C (2002). Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis. Cancer Res 62, 2999-3004.
28. Abate-Shen C, Shen MM, and Gelmann E (2008). Integrating differentiation and cancer: the Nkx3.1 homeobox gene in prostate organogenesis and carcinogenesis. Differentiation 76, 717-727.
29. Chen H, Nandi AK, Li X, and Bieberich CJ (2002). NKX-3.1 interacts with prostate-derived Ets factor and regulates the activity of the PSA promoter. Cancer Res 62, 338-340.
30. Lei Q, Jiao J, Xin L, Chang CJ, Wang S, Gao J, Gleave ME, Witte ON, Liu X, and Wu H (2006). NKX3.1 stabilizes p53, inhibits AKT activation, and blocks prostate cancer initiation caused by PTEN loss. Cancer Cell 9, 367-378.
31. Taylor BS, Schultz N, Hieronymus H, Gopalan A, Xiao Y, Carver BS, Arora VK, Kaushik P, Cerami E, Reva B, et al. (2010). Integrative genomic profiling of human prostate cancer. Cancer Cell 18, 11-22.
32. Hurt EM, Kawasaki BT, Klarmann GJ, Thomas SB, and Farrar WL (2008). CD44+ CD24- prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. Br J Cancer 98, 756-765.
33. Goldstein AS and Witte ON (2013). Does the microenvironment influence the cell types of origin for prostate cancer? Genes Dev 27, 1539-1544.
34. Okubo Y, Sugawara T, Abe-Koduka N, Kanno J, Kimura A, and Saga Y (2012). Lfng regulates the synchronized oscillation of the mouse segmentation clock via trans-repression of Notch signalling. Nat Commun 3, 1141.
35. Bin Hafeez B, Adhami VM, Asim M, Siddiqui IA, Bhat KM, Zhong W, Saleem M, Din M, Set-aletal/et-aluri V, and Mukhtar H (2009). Targeted knockdown of Notch1 inhibits invasion of human prostate cancer cells concomitant with inhibition of matrix metalloproteinase-9 and urokinase plasminogen activator. Clin Cancer Res 15, 452-459.
36. Domingo-Domenech J, Vidal SJ, Rodriguez-Bravo V, Castillo-Martin M, Quinn SA, Rodriguez-Barrueco R, Bonal DM, Charytonowicz E, Gladoun N, de la Iglesia-Vicente J, et al. (2012). Suppression of acquired docetaxel resistance in prostate cancer through depletion of Notch- and Hedgehogdependent tumor-initiating cells. Cancer Cell 22, 373-388.
37. Santagata S, Demichelis F, Riva A, Varambally S, Hofer MD, Kutok JL, Kim R, Tang J, Montie JE, Chinnaiyan AM, et al. (2004). JAGGED1 expression is associated with prostate cancer metastasis and recurrence. Cancer Res 64, 6854-6857.
38. Danza G, Di Serio C, Ambrosio MR, Sturli N, Lonetto G, Rosati F, Rocca BJ, Ventimiglia G, Del Vecchio MT, Prudovsky I, et al. (2013). Notch3 is activated by chronic hypoxia and contributes to the progression of human prostate cancer. Int J: Cancer 133, 2577-2586.
39. Bjerke GA, Yang CS, Frierson HF, Paschal BM, and Wotton D (2013). Activation of Akt signaling in prostate induces a TGFβ-mediated restraint on cancer progression and metastasis. Oncogene, E-pub ahead of print Sep 2.